Professor Sandy Middleton FACN, FAAN Professor of Nursing, Director Nursing Research Institute, St Vincent’s Health Network Sydney, St Vincent’s Hospital Melbourne and Australian Catholic University
NEW SOUTH WALES, AUSTRALIA
Watch Professor Sandy Middleton talk about nurse-led protocols for stroke patients, based on Australian Catholic University research, making changes to policy, guidelines and clinical practice in Europe and Australia. These have decreased patient mortality, dependency & treatment costs.
-
Digital Biomarkers and AI for Optimal Diagnosis, Treatment, and Decision-Making
Associate Professor Johan Verjans is a clinician-scientist with a strong focus on cross-disciplinary translational research. In his role as Deputy Director at the Australian Institute for Machine Learning (AIML)—one of the world’s premier machine learning institutes, with over 200 researchers—and as Group Leader of Artificial Intelligence at the South Australian Health and Medical Research Institute (SAHMRI), he integrates his expertise in molecular medicine, clinical research, and advanced imaging with machine learning applications. This unique combination enables him to drive the translation of cutting-edge AI research into practical medical applications. He works with global teams from multinationals on AI problems.
-
Mental wellbeing in rural and regional communities dealing with environmental challenges
Associate Professor Suzie Cosh is a psychologist and clinical researcher. Her work focuses on the intersection of climate change and mental health and she currently leads a body of work that focuses on supporting small rural communities to recover from and prepare for extreme weather events such as bushfires, floods and droughts.
-
Tyrosine Kinases in cancer recurrence
Dr Yu Yu leads the Oncology and Gynaecology Research Program at Curtin Medical Research Institute . Dr Yu is also a senior research fellow at Curtin Medical School.
Dr Yu Yu’s laboratory is working on better ways to treat cancers, particularly ovarian cancers which are resistant to conventional chemotherapy. The aims are for better informed treatment choice and reducing unnecessary exposure to ineffective chemotherapy and its potential adverse effects.
